This difference appeared to have been caused by results in VAP patients in whom there was a higher mortality in the tigecycline group that did not reach statistical significance [ 42 ].
1
—
—
This difference appeared to have been caused by results in VAP patients in whom there was a higher mortality in the tigecycline group that did not reach statistical significance [ 42 ].